申请人:Hendricks Robert Than
公开号:US08481541B2
公开(公告)日:2013-07-09
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I,
wherein the variables Q, R2, R3, and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用新型吡咯吡嗪衍生物(式I),其中变量Q、R2、R3和Y的定义如本文所述,这些衍生物抑制JAK和SYK,并且对于治疗自身免疫和炎症性疾病是有用的。